The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

The need for systemic corticosteroids fell by 88%, and the need for surgery fell by 98%. Nasal polyp and congestion scores fell, along with loss of smell and total symptom scores. SAN DIEGO ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

Nasal steroid sprays are used to treat chronic sinusitis and allergies that affect your breathing, like hay fever. They can also be used to treat snoring and nasal polyps, noncancerous growths in ...

The CHMP opinion covers use of Dupixent with intranasal corticosteroids – the standard first-line treatment - in adults with the condition. In CRSwNP polyps obstruct the sinuses and nasal ...

Recent studies examine the burden of CRSwNP, looking at quality of life in patients and caregivers and assessing how CRSwNP ...

For chronic rhinosinusitis with nasal polyps, at least 3% of adults reported headache, injection site reactions, arthralgia, upper abdominal pain, and dizziness. At least 3% of food allergy ...

Others: This category includes antihistamines and other medications that assist in managing symptoms associated with nasal polyps. In 2020, the corticosteroids segment dominated the market ...

had received prior treatment with systemic corticosteroids (SCS), or were intolerant to SCS (N=528). Results showed patients treated with depemokimab had significant improvements in nasal polyp ...

A new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

Tezepelumab reduced the size of nasal polyps and the severity of nasal congestion in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, in a placebo-controlled study.